NCT07077213View on ClinicalTrials.gov

18F-FAPI-74 in Tuberculosis Patients

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

December 1, 2027

Conditions
Tuberculosis, Pulmonary
Interventions
COMBINATION_PRODUCT

18F-FAPI-74

10 millicurie (mCi) of 18F-FAPI-74 in adult tuberculosis patient followed by a PET/CT scan, performed during the first 6 weeks of treatment and a second dose of 10 millicurie (mCi) of 18F-FAPI-74 in adult tuberculosis patient followed by a PET/CT scan within 6 weeks after tuberculosis treatment completion.

Sponsors

Collaborators (1)

SOFIE
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

SOFIE

INDUSTRY

lead

Johns Hopkins University

OTHER